First AD

Second AD

Stone is professor of medicine at Harvard Medical School and the Edward A Fox Chair in Medicine at the Massachusetts General Hospital. He has treated IgG4-related disease (IgG4-RD) since its emergence in recent years and is passionate about educating patients and fellow healthcare providers (HCPs) about the indolent and systemic nature of this disease.

Reflecting on the Trial Landscape in GCA and History of Approved Agents

This video covers the following questions:

Please provide an overview of clinical trial data for FDA-approved targeted therapies for GCA (such as tocilizumab and upadacitinib). (

Clinical

clinical page is a resource for content on every specialty, disease, and topic available on our medical news site.

Video Series

Navigating Giant Cell Arteritis: Diagnosis, Management, and the Road Ahead

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Reflecting on the Trial Landscape in GCA and History of Approved Agents 